Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer

Abstract Background Several prognostic signatures for early oestrogen receptor-positive (ER+) breast cancer have been established with a 10-year follow-up. We tested the hypothesis that signatures optimised for 0–5-year and 5–10-year follow-up separately are more prognostic than a single signature o...

Full description

Bibliographic Details
Main Authors: Richard Buus, Belinda Yeo, Adam R. Brentnall, Marie Klintman, Maggie Chon U. Cheang, Komel Khabra, Ivana Sestak, Qiong Gao, Jack Cuzick, Mitch Dowsett
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Oestrogen receptor
Prognostic tests
Biomarkers
Late recurrence
Online Access:http://link.springer.com/article/10.1186/s13058-018-1040-9

Internet

http://link.springer.com/article/10.1186/s13058-018-1040-9

Similar Items